These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33349879)

  • 21. Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study.
    Dubray CL; Sircar AD; Beau de Rochars VM; Bogus J; Direny AN; Ernest JR; Fayette CR; Goss CW; Hast M; O'Brian K; Pavilus GE; Sabin DF; Wiegand RE; Weil GJ; Lemoine JF
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008298. PubMed ID: 32511226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How Does the Proportion of Never Treatment Influence the Success of Mass Drug Administration Programs for the Elimination of Lymphatic Filariasis?
    Kura K; Stolk WA; Basáñez MG; Collyer BS; de Vlas SJ; Diggle PJ; Gass K; Graham M; Hollingsworth TD; King JD; Krentel A; Anderson RM; Coffeng LE
    Clin Infect Dis; 2024 Apr; 78(Supplement_2):S93-S100. PubMed ID: 38662701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multicenter, community-based, mixed methods assessment of the acceptability of a triple drug regimen for elimination of lymphatic filariasis.
    Krentel A; Basker N; Beau de Rochars M; Bogus J; Dilliott D; Direny AN; Dubray C; Fischer PU; Ga AL; Goss CW; Hardy M; Howard C; Jambulingam P; King CL; Laman M; Lemoine JF; Mallya S; Robinson LJ; Samuela J; Schechtman KB; Steer AC; Supali T; Tavul L; Weil GJ
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009002. PubMed ID: 33657090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of albendazole in programmes to eliminate lymphatic filariasis.
    Ottesen EA; Ismail MM; Horton J
    Parasitol Today; 1999 Sep; 15(9):382-6. PubMed ID: 10461168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The development of albendazole for lymphatic filariasis.
    Horton J
    Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S33-40. PubMed ID: 19843396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modelling lymphatic filariasis elimination in American Samoa: GEOFIL predicts need for new targets and six rounds of mass drug administration.
    McLure A; Graves PM; Lau C; Shaw C; Glass K
    Epidemics; 2022 Sep; 40():100591. PubMed ID: 35816826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Setting the stage for a Global Programme to Eliminate Lymphatic Filariasis: the first 125 years (1875-2000).
    Ottesen EA; Horton J
    Int Health; 2020 Dec; 13(Suppl 1):S3-S9. PubMed ID: 33349877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Albendazole for the control and elimination of lymphatic filariasis: systematic review.
    Critchley J; Addiss D; Ejere H; Gamble C; Garner P; Gelband H;
    Trop Med Int Health; 2005 Sep; 10(9):818-25. PubMed ID: 16135187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are Alternative Strategies Required to Accelerate the Global Elimination of Lymphatic Filariasis? Insights From Mathematical Models.
    Stolk WA; Prada JM; Smith ME; Kontoroupis P; de Vos AS; Touloupou P; Irvine MA; Brown P; Subramanian S; Kloek M; Michael E; Hollingsworth TD; de Vlas SJ
    Clin Infect Dis; 2018 Jun; 66(suppl_4):S260-S266. PubMed ID: 29860286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GlaxoSmithKline and Merck: private-sector collaboration for the elimination of lymphatic filariasis.
    Gustavsen KM; Bradley MH; Wright AL
    Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S11-5. PubMed ID: 19843393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and Safety of a Single Dose of Ivermectin, Diethylcarbamazine, and Albendazole for Treatment of Lymphatic Filariasis in Côte d'Ivoire: An Open-label Randomized Controlled Trial.
    Bjerum CM; Ouattara AF; Aboulaye M; Kouadio O; Marius VK; Andersen BJ; Weil GJ; Koudou BG; King CL
    Clin Infect Dis; 2020 Oct; 71(7):e68-e75. PubMed ID: 31641754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of ivermectin and albendazole combination in suppressing transmission of lymphatic filariasis following mass administration in Tanzania: a prospective cohort study.
    Fimbo AM; Mnkugwe RH; Mlugu EM; Kunambi PP; Malishee A; Minzi OMS; Kamuhabwa AAR; Aklillu E
    Infect Dis Poverty; 2024 Jun; 13(1):44. PubMed ID: 38867265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Importance of Partnership in the Rollout of Triple-Drug Therapy to Eliminate Lymphatic Filariasis in the Pacific.
    Rainima-Qaniuci M; Lepaitai HB; Bhagirov R; Padmasiri E; Naseri T; Thomsen R; Won KY; Brant TA; Dodd E; Nua MT; Utu F; Tufa A; Chutaro E; Camacho J; Suiaunoa-Scanlan L; Thean LJ; Mani J; Hardy M; Samuela J; Romani L; Kaldor J; Steer AC; Faktaufon D; Bechu V; Naqio F; Sosene V; Sekihara M; Otaki J; Buhagiar TS; Yajima A
    Am J Trop Med Hyg; 2022 May; 106(5_Suppl):39-47. PubMed ID: 35292579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elimination of transmission of lymphatic filariasis in Egypt.
    Molyneux DH
    Lancet; 2006 Mar; 367(9515):966-8. PubMed ID: 16564345
    [No Abstract]   [Full Text] [Related]  

  • 35. Ongoing transmission of lymphatic filariasis in Samoa 4.5 years after one round of triple-drug mass drug administration.
    Mayfield HJ; Sartorius B; Sheridan S; Howlett M; Martin BM; Thomsen R; Tofaeono-Pifeleti R; Viali S; Graves PM; Lau CL
    PLoS Negl Trop Dis; 2024 Jun; 18(6):e0012236. PubMed ID: 38935622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of the microfilaraemia of asymptomatic brugian filariasis with single doses of ivermectin, diethylcarbamazine or albendazole, in various combinations.
    Shenoy RK; Dalia S; John A; Suma TK; Kumaraswami V
    Ann Trop Med Parasitol; 1999 Sep; 93(6):643-51. PubMed ID: 10707109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding the community impact of lymphatic filariasis: a review of the sociocultural literature.
    Wynd S; Melrose WD; Durrheim DN; Carron J; Gyapong M
    Bull World Health Organ; 2007 Jun; 85(6):493-8. PubMed ID: 17639248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators.
    Jambulingam P; Subramanian S; de Vlas SJ; Vinubala C; Stolk WA
    Parasit Vectors; 2016 Sep; 9(1):501. PubMed ID: 27624157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
    Thomsen EK; Sanuku N; Baea M; Satofan S; Maki E; Lombore B; Schmidt MS; Siba PM; Weil GJ; Kazura JW; Fleckenstein LL; King CL
    Clin Infect Dis; 2016 Feb; 62(3):334-341. PubMed ID: 26486704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes.
    Bockarie MJ; Alexander ND; Hyun P; Dimber Z; Bockarie F; Ibam E; Alpers MP; Kazura JW
    Lancet; 1998 Jan; 351(9097):162-8. PubMed ID: 9449870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.